What is Uplisting?
CorporateDefinition
The process of a cannabis company moving its stock listing from OTC markets or the CSE to a major exchange like NYSE or NASDAQ, typically requiring federal legalization or rescheduling.
Understanding Uplisting
Uplisting is an important concept for cannabis investors to understand. It relates to the corporate structure, governance, or organizational aspects of publicly traded cannabis companies. As the industry matures, these concepts become increasingly relevant for evaluating management quality and corporate health.
Understanding uplisting provides insight into how cannabis companies are organized and governed. This knowledge helps investors assess management competence, alignment with shareholders, and overall corporate quality.
For cannabis companies specifically, uplisting may have unique implications due to the industry's rapid growth phase, complex multi-jurisdiction operations, and evolving regulatory requirements.
How Uplisting Applies to Cannabis Stocks
In the cannabis industry, uplisting takes on particular significance due to the sector's unique operating environment. The combination of rapid growth, evolving regulation, and complex multi-jurisdiction operations creates dynamics that investors in more established sectors may not encounter.
Live Cannabis Stock Examples
| # | Ticker | Company | Price | Market Cap |
|---|---|---|---|---|
| 1 | JAZZ | Jazz Pharmaceuticals | $178.55 | $10.99B |
| 2 | SMG | Scotts Miracle-Gro | $60.96 | $3.54B |
| 3 | CURLF | Curaleaf Holdings | $2.36 | $1.80B |
| 4 | TPB | Turning Point Brands | $90.62 | $1.73B |
| 5 | GTBIF | Green Thumb Industries | $6.56 | $1.54B |
Data updates periodically. Visit individual stock pages for real-time figures.
Key Takeaways
- Uplisting is an important concept for cannabis investors to understand and monitor.
- Evaluate how this concept applies specifically to the cannabis industry's unique operating environment.
- Track developments and changes related to uplisting as the industry matures.
Related Terms
Stocks that trade at a very low price, typically under $5 per share, often on OTC markets with lower liquidity and higher volatility.
Over-the-counter markets where securities are traded directly between parties without a centralized exchange, commonly used by cannabis companies unable to list on major exchanges.
The process of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, which would eliminate Section 280E tax burdens and open new research and business pathways.
A Canadian stock exchange that became the primary listing venue for US cannabis companies, as the TSX and major US exchanges prohibit companies violating federal drug laws.
The percentage of a company's shares held by large financial organizations such as mutual funds, pension funds, and hedge funds, often limited in cannabis due to federal prohibition.
Related Cannabis Stock Pages
Frequently Asked Questions
What is a good Uplisting for cannabis stocks?
Where can I find Uplisting data on Cannabismarketcap?
Why does Uplisting matter for cannabis investors?
More Corporate Terms
Disclaimer
The information on this page is provided for educational purposes only and does not constitute financial, investment, or legal advice. Cannabismarketcap is a data aggregation platform and does not recommend or endorse any specific investment. Cannabis stocks carry significant risks including regulatory uncertainty, federal illegality, and high volatility. Always conduct your own research and consult a licensed financial advisor before making investment decisions. Past performance does not guarantee future results.